Free Trial

Corbus Pharmaceuticals (CRBP) SEC Filings & 10K Form

$45.02
+3.64 (+8.80%)
(As of 05/24/2024 ET)

Recent Corbus Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/20/2024
3:30 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:00 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:30 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
8:17 AM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:58 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:59 PM
Corbus Pharmaceuticals (Filer)
Form DEFA14A
03/22/2024
4:05 PM
Corbus Pharmaceuticals (Filer)
Form PRE 14A
03/20/2024
11:15 PM
Corbus Pharmaceuticals (Filer)
Form EFFECT
03/20/2024
4:07 PM
Corbus Pharmaceuticals (Filer)
Form 424B3
03/20/2024
4:10 PM
Corbus Pharmaceuticals (Filer)
Form 10-K/A
03/20/2024
4:13 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:52 PM
Corbus Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/12/2024
4:19 PM
Corbus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2024
7:15 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
4:34 PM
Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:13 PM
Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:07 PM
Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/14/2024
3:45 PM
Corbus Pharmaceuticals (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
Form SC 13G/A
02/14/2024
2:19 PM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:26 PM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:47 PM
Corbus Pharmaceuticals (Subject)
Cormorant Global Healthcare Master Fund, LP (Filed by)
Form SC 13G
02/05/2024
7:12 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
7:55 PM
Corbus Pharmaceuticals (Filer)
Form 8-K/A
02/01/2024
4:27 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
4:09 PM
Corbus Pharmaceuticals (Filer)
Form 424B5
01/31/2024
8:16 AM
Corbus Pharmaceuticals (Filer)
Form S-3MEF
01/30/2024
7:40 PM
Corbus Pharmaceuticals (Filer)
Form 424B5
01/30/2024
7:41 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
5:07 PM
Corbus Pharmaceuticals (Issuer)
HOLMER ALAN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:56 PM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:18 PM
Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2024
3:23 PM
Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:40 PM
Corbus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
01/29/2024
6:30 AM
Corbus Pharmaceuticals (Filer)
Form 424B3
01/29/2024
6:31 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
7:45 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
4:25 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
3:57 PM
Corbus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
8:23 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
4:21 PM
Corbus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2023
8:05 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Truth about Trump you’ve never heard (Ad)

Everything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump.

For the full story, click here.
08/03/2023
7:44 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
11:15 PM
Corbus Pharmaceuticals (Filer)
Form EFFECT
06/13/2023
3:58 PM
Corbus Pharmaceuticals (Filer)
Form 424B3
06/12/2023
3:53 PM
Corbus Pharmaceuticals (Filer)
Form S-3/A
05/31/2023
8:05 PM
Corbus Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CRBP) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners